Please try another search
To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally.
| Name | Title | Since | Until |
|---|---|---|---|
| Bartjan van Hulten | Portfolio Manager | 2024 | Now |
| Biography | Mr. van Hulten, Executive Director, is an analyst in the U.S. Equity Research Group based in London, specializing in healthcare. Additionally, Mr. van Hulten was named a co-portfolio manager on the JPMorgan Global Healthcare strategy as of March 1, 2024. | ||
| Dominic Valder | - | 2022 | Now |
| Holly Morris | - | 2022 | 2024 |
| Biography | Ms. Fleiss is a Managing Director at JPMIM and a co-portfolio manager in the JPMorgan U.S. Equity Group. She has been with the firm since 2012. | ||
| Matthew G. Cohen | Managing Director | 2015 | 2024 |
| Biography | Matthew G. Cohen, M.D., managing director, is a research analyst in the U.S. Equity Group. An employee since 2005, Dr. Cohen has been portfolio manager since 2015 and a research analyst in the firm’s U.S. Equity Group since 2005. Before joining the firm, Matthew was a senior healthcare analyst at Medici Healthcare and a senior analyst covering medical products at Narragansett Asset Management, a New York-based healthcare hedge fund. Prior to that, Dr. Cohen was a resident surgeon in the Department of General Surgery at the North Shore University Hospital NYU School of Medicine. Matthew holds an M.B.A. from New York University Stern School of Business and an M.D. from McGill University in Montreal. | ||
| Anne Marden | - | 2009 | 2023 |
| Biography | Anne Marden, managing director, is a research analyst with the European Equity Research Team with responsibility for the pharmaceutical and healthcare sectors, and is co-portfolio manager of the Global Healthcare Fund. An employee since 1986, she obtained a B.A. in economics from Princeton and earned an M.B.A. from INSEAD. She is a holder of the CFA designation. | ||
| Laurence McGrath | Executive Director | 2019 | 2022 |
| Biography | Laurence McGrath, executive director, is an analyst in Equity Research with over 20 years of industry experience. An employee since 2010, Laurence is responsible for analysing and investing in the U.S. Large Cap healthcare equipment and services sector. Before joining JPMorgan, he was a healthcare equipment and services analyst with Pioneer Investments. He holds a Bachelor of Commerce in banking and finance from the University College Dublin and a M.Sc. in investment and treasury management from Dublin City University. | ||
| Premal Pajwani | - | 2014 | 2017 |
| Scott Braunstein | Portfolio Manager, Research Analyst | 2009 | 2014 |
| Biography | Scott Braunstein is a portfolio manager and research analyst of pharmaceuticals and medical technology stocks and is a co-analyst of the Analyst Portfolio Strategy of JPMIM since July, 2004. Prior to joining JPMIM, he worked from 2000 to 2002 at Deutsche Bank Alex Brown and from 1999 to 2000 as Director of Operations for Defined Health. | ||
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
